IFNL1 and neoplasm: Upon TLR-3 triggering and induction of the transcription factor IRF3, cDC1s can also produce type III IFN (IFNλ1/IL29 and IFNλ2/IL28A), rendering them important for antiviral and anti-tumor immune responses [9].